Overall Survival Improvement in Patients with Lung Cancer and Bone Metastases Treated with Denosumab Versus Zoledronic Acid: Subgroup Analysis from a Randomized Phase 3 Study

2012339 citationsJournal Articlebronze Open Access

Authors

Good health and well-being

Published in: Journal of Thoracic Oncology

Volume 7, Issue 12, pp. 1823-1829

Field-Weighted Citation Impact: 11.63